Korro Bio, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Korro Bio, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2017 to 2024.
  • Korro Bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $139K, a 99.7% decline year-over-year.
  • Korro Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $69.4M, a 63.1% decline from 2023.
  • Korro Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $188M.
  • Korro Bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $18K.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $69.4M -$118M -63.1% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-18
2023 $188M +$188M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-18
2022 $18K* -$1.34M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $1.36M -$55.3M -97.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $56.7M -$85.3M -60.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $142M +$100M +240% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-29
2018 $41.7M +$13.7M +49.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-26
2017 $28M Jan 1, 2017 Dec 31, 2017 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.